CD79B
Overview
CD79B encodes the Ig-beta component of the B-cell receptor. ITAM-domain mutations (notably Y196) drive chronic active BCR signaling and are recurrent in activated B-cell DLBCL and primary CNS lymphoma.
Alterations observed in the corpus
- Mutated in 48% of PCNSLs profiled with MSK-HemePACT in the MSK ibrutinib phase II trial PMID:38995739.
- Mutations serve as a key classifier for the MCD subtype in the LymphGen molecular classification algorithm, alongside MYD88 mutations; detectable by targeted 400-gene clinical NGS panels (e.g., MSK-IMPACT Heme) with high fidelity PMID:38497151.
- Identified as recurrently mutated in DLBCL and FL by whole-genome/exome sequencing of non-Hodgkin lymphomas PMID:21796119
- Identified as a recurrently mutated gene in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing of 55 tumors PMID:22343534
- Activating mutations in 40% of PCNSL cases; frequently co-occur with MYD88 L265P mutations (3 of 4 CD79B-mutant cases); higher prevalence than nodal DLBCL PMID:25991819
- placeholder
Cancer types (linked)
- PCNSL — canonical BCR-pathway driver; part of the non-germinal-center (Hans classifier) profile that dominated the MSK ibrutinib cohort (21/25, 84%) PMID:38995739.
- DLBCLNOS — established ABC-subtype driver PMID:38995739; CD79B mutations define the MCD subtype in conjunction with MYD88 mutations; validated by LymphGen classification on a real-world clinical NGS panel PMID:38497151.
Co-occurrence and mutual exclusivity
- Co-occurs with MYD88, CARD11, and TBL1XR1 in non-GCB PCNSL PMID:38995739.
Therapeutic relevance
- CD79B mutations drive BCR-pathway dependence, the rationale for ibrutinib treatment in PCNSL; the MSK phase II trial did not report an independent PFS association for CD79B status PMID:38995739.
Open questions
- Whether CD79B status refines the TBL1XR1/MYD88 predictive signal for BTK inhibitor benefit in PCNSL PMID:38995739.
Sources
This page was processed by crosslinker on 2026-05-14. - PMID:21796119
This page was processed by crosslinker on 2026-05-14. - PMID:22343534
This page was processed by crosslinker on 2026-05-14. - PMID:25991819
This page was processed by crosslinker on 2026-05-14. - PMID:28985567
This page was processed by wiki-cli on 2026-05-15.